Pulmonary Arterial Hypertension Patients Treatment

INDUSTRY: Healthcare

TARGETED AUDIENCE: Pulmonologist

COUNTRY: UK & FRANCE

BACKGROUND & KEY OBJECTIVES:

  • The study’s goal was to determine the ratio of Pulmonary Arterial Hypertension (PAH) patients treated by a pulmonologist in the previous 12 months and overall in terms of symptoms, WHO patient classification groups, available treatment options, and doctor-prescribed regimens.
  • The survey questions primarily targeted patients treated at the entire practice/treatment center, with the distribution of Lines of Therapy received in the previous year and personally initiated treatment classes such as ERAs, PDE-5is, Oral Prostacyclin IP receptors, etc.
  • To determine which Regimens (Monotherapies & Combination Therapies) are prescribed by their pulmonologist for patients with pulmonary arterial hypertension.

METHODOLOGIES & APPROACH:

  • A probability sample of hospital-based pulmonologists who diagnose and treat patients with pulmonary arterial hypertension (PAH).
  • Length of quantitative survey: 30 Minutes
  • Targeted countries: UK & France
  • The survey contains questions in several sections:
    • Patient segmentation
    • Treatment Plan
    • Available and in-development regimens
    • Pulmonologist-preferred regimens

OUR SOLUTION:

  • The above study provided the customer with information on the overall distribution of Pulmonary Arterial Hypertension (PAH) patients.
  • Initial input on accessible market regimens generally favored by pulmonologists to address patients’ problems.

Leave a Comment

Your email address will not be published. Required fields are marked *